Phase 3 Acute Respiratory Distress Syndrome (ARDS) Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 2Phase 3
A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation
Acute Respiratory Distress Syndrome (ARDS)Acute Lung Injury(ALI)Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome
Shanghai University of Traditional Chinese Medicine60 enrolled1 locationNCT07342205
Recruiting
Phase 3
To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome (ARDS)
Staidson (Beijing) Biopharmaceuticals Co., Ltd406 enrolled15 locationsNCT07208591
Recruiting
Phase 2Phase 3
Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury
Nonintubated Acute Respiratory Distress Syndrome (ARDS)Pathogen-associated Lung Injury
Bentley J. Bobrow1,100 enrolled1 locationNCT07086755
Recruiting
Phase 3
Pirfenidone to Prevent Fibrosis in Ards.
Acute Respiratory Distress Syndrome (ARDS)
Università Vita-Salute San Raffaele130 enrolled17 locationsNCT05075161
Recruiting
Phase 3
Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)
Acute Respiratory Distress Syndrome (ARDS)
Consorcio Centro de Investigación Biomédica en Red (CIBER)350 enrolled10 locationsNCT05847517